Insider Transactions in Q3 2021 at Incyte Corp (INCY)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2021
|
Paul J Clancy Director |
BUY
Grant, award, or other acquisition
|
Direct |
321
+4.04%
|
$21,828
$68.78 P/Share
|
|
Sep 30
2021
|
Wendy L Dixon Director |
BUY
Grant, award, or other acquisition
|
Direct |
244
+1.39%
|
$16,592
$68.78 P/Share
|
|
Sep 30
2021
|
Jacqualyn A Fouse Director |
BUY
Grant, award, or other acquisition
|
Direct |
271
+3.3%
|
$18,428
$68.78 P/Share
|
|
Sep 30
2021
|
Edmund Harrigan Director |
BUY
Grant, award, or other acquisition
|
Direct |
237
+4.46%
|
$16,116
$68.78 P/Share
|
|
Sep 30
2021
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
786
+0.01%
|
-
|
|
Sep 27
2021
|
Otis W Brawley Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,255
+50.0%
|
-
|
|
Sep 24
2021
|
Maria E Pasquale EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
382
+1.04%
|
$24,830
$65.36 P/Share
|
|
Sep 20
2021
|
Paula J Swain EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
1,356
+2.18%
|
$98,988
$73.21 P/Share
|
|
Sep 01
2021
|
Dashyant Dhanak EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
388
-1.21%
|
$29,488
$76.71 P/Share
|
|
Aug 02
2021
|
Dashyant Dhanak EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
389
-1.2%
|
$29,953
$77.49 P/Share
|
|
Jul 29
2021
|
Vijay K Iyengar EVP, GMAPPS |
SELL
Open market or private sale
|
Direct |
4,911
-15.39%
|
$383,058
$78.29 P/Share
|
|
Jul 06
2021
|
Barry P Flannelly EVP & General Manager US |
SELL
Payment of exercise price or tax liability
|
Direct |
273
-0.49%
|
$22,659
$83.34 P/Share
|
|
Jul 06
2021
|
Herve Hoppenot Chairman / CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,562
-0.47%
|
$129,646
$83.34 P/Share
|
|
Jul 06
2021
|
Vijay K Iyengar EVP, GMAPPS |
SELL
Payment of exercise price or tax liability
|
Direct |
401
-1.24%
|
$33,283
$83.34 P/Share
|
|
Jul 06
2021
|
Paula J Swain EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
273
-0.46%
|
$22,659
$83.34 P/Share
|
|
Jul 06
2021
|
Steven H Stein EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
402
-0.39%
|
$33,366
$83.34 P/Share
|
|
Jul 06
2021
|
Yao Wenqing EVP, Head of Discovery Chem |
SELL
Payment of exercise price or tax liability
|
Direct |
405
-0.41%
|
$33,615
$83.34 P/Share
|
|
Jul 06
2021
|
Paul Trower Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
104
-0.32%
|
$8,632
$83.34 P/Share
|
|
Jul 02
2021
|
Dashyant Dhanak EVP & Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,573
-4.63%
|
$130,559
$83.58 P/Share
|
|
Jul 02
2021
|
Dashyant Dhanak EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,853
+18.76%
|
-
|
|
Jul 02
2021
|
Barry P Flannelly EVP & General Manager US |
SELL
Payment of exercise price or tax liability
|
Direct |
1,990
-3.42%
|
$165,170
$83.58 P/Share
|
|
Jul 02
2021
|
Barry P Flannelly EVP & General Manager US |
BUY
Grant, award, or other acquisition
|
Direct |
7,853
+11.9%
|
-
|
|
Jul 02
2021
|
Herve Hoppenot Chairman / CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,089
-4.63%
|
$1,335,387
$83.58 P/Share
|
|
Jul 02
2021
|
Herve Hoppenot Chairman / CEO |
BUY
Grant, award, or other acquisition
|
Direct |
44,264
+11.3%
|
-
|
|
Jul 02
2021
|
Vijay K Iyengar EVP, GMAPPS |
SELL
Payment of exercise price or tax liability
|
Direct |
1,990
-5.8%
|
$165,170
$83.58 P/Share
|
|
Jul 02
2021
|
Vijay K Iyengar EVP, GMAPPS |
BUY
Grant, award, or other acquisition
|
Direct |
7,853
+18.63%
|
-
|
|
Jul 02
2021
|
Maria E Pasquale EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,241
-5.89%
|
$186,003
$83.58 P/Share
|
|
Jul 02
2021
|
Maria E Pasquale EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
7,853
+17.11%
|
-
|
|
Jul 02
2021
|
Christiana Stamoulis EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
516
-1.27%
|
-
|
|
Jul 02
2021
|
Christiana Stamoulis EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,853
+16.15%
|
-
|
|
Jul 02
2021
|
Paula J Swain EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
1,990
-3.22%
|
$165,170
$83.58 P/Share
|
|
Jul 02
2021
|
Paula J Swain EVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
7,853
+11.26%
|
-
|
|
Jul 02
2021
|
Steven H Stein EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,953
-2.8%
|
$245,099
$83.58 P/Share
|
|
Jul 02
2021
|
Steven H Stein EVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,853
+6.93%
|
-
|
|
Jul 02
2021
|
Yao Wenqing EVP, Head of Discovery Chem |
SELL
Payment of exercise price or tax liability
|
Direct |
2,953
-2.9%
|
$245,099
$83.58 P/Share
|
|
Jul 02
2021
|
Yao Wenqing EVP, Head of Discovery Chem |
BUY
Grant, award, or other acquisition
|
Direct |
7,853
+7.15%
|
-
|
|
Jul 02
2021
|
Paul Trower Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
872
-2.62%
|
$72,376
$83.58 P/Share
|
|
Jul 02
2021
|
Paul Trower Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,521
+11.97%
|
-
|
|
Jul 01
2021
|
Dashyant Dhanak EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
396
-1.49%
|
$33,264
$84.09 P/Share
|